Breast Cancer Clinical Trials in Philadelphia

Showing 501-520 of 673 trials

MRI to Detect Breast Tumors in Women

NCT00003302

RATIONALE: New imaging procedures, such as MRI, may improve the ability to detect breast tumors. PURPOSE: Diagnostic study to determine the value of MRI in detecting breast tumors in women who have had suspicious mammographic or clinical examinations.

Breast Cancer

Abramson Cancer Center at Penn Medicine1,500 participantsStarted May 1998

Little Rock, Arkansas, United States • Los Angeles, California, United States • San Francisco, California, United States +12 more locations

COMPLETEDNA< 1 mile

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

NCT00003736

RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for breast cancer. Diagnostic procedures such as MRI may improve the ability to detect breast cancer. PURPOSE: Screening and diagnostic trial to study the effectiveness of MRI scans in women who are at high risk for developing breast cancer.

Breast Cancer

Abramson Cancer Center at Penn Medicine200 participantsStarted Jun 1999

San Francisco, California, United States • Denver, Colorado, United States • Denver, Colorado, United States +9 more locations

MRI to Detect Breast Tumors in Women

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

Breast Cancer Trials in Other Cities

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

Multi-peptide Vaccine With Basilixumab for Breast Cancer

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT)

A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi

Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation

Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer

Nueva Vida Intervention for Latina Breast Cancer Survivors and Caregivers

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Other Conditions in Philadelphia